A stye (hordeolum) is one of the most common eye complaints that walks into a community pharmacy. Most resolve within one to two weeks with warm compresses and basic hygiene. But some patients return repeatedly — the same red, tender lump on the eyelid, month after month. Recurrent styes, and their chronic cousins chalazia, point to an underlying problem that pharmacy teams can help manage before it reaches a surgeon.

Stye versus chalazion: the distinction matters

A stye (hordeolum) is an acute bacterial infection of an eyelid gland. An external stye affects a lash follicle or its associated gland of Zeis or Moll. An internal stye affects a meibomian gland deeper within the eyelid. Styes are typically painful, red, swollen, and may have a visible pus point.

A chalazion is a chronic, sterile granuloma of a meibomian gland. It develops when the gland's duct becomes blocked, oil accumulates, and the surrounding tissue mounts a granulomatous inflammatory response. Chalazia are usually painless (after any initial acute phase), firm, and can persist for weeks or months. They are the most common cause of a persistent eyelid lump.

The progression is often: blocked meibomian gland → internal stye (if infected) → chalazion (if the blockage persists and the acute infection settles). Understanding this sequence explains why managing the underlying gland blockage is the key to preventing recurrence.

Why styes recur

Recurrent styes almost always indicate underlying meibomian gland dysfunction (MGD) or chronic blepharitis — both of which cause the meibomian glands to produce abnormally thick, waxy secretions that block the gland orifices. Risk factors include:

• Chronic blepharitis (anterior or posterior) — the single most common underlying cause
• Rosacea — ocular rosacea frequently causes meibomian gland dysfunction
• Demodex mites — these microscopic parasites colonise lash follicles and contribute to anterior blepharitis
• Hormonal factors — meibomian gland secretion changes with androgen levels, which is why chalazia are common in young adults and post-menopausal women
• Contact lens wear — chronic mechanical irritation of the lid margin
• Poor makeup hygiene — expired eye cosmetics, sleeping in eye makeup, sharing applicators

The pharmacy management plan

Step 1: Warm compresses (the foundation)

For both acute styes and established chalazia, warm compresses are the first-line treatment recommended by NICE CKS. The goal is to soften the solidified meibomian gland secretion and allow the blocked duct to drain.

Technique that works:

• Use a clean flannel soaked in water as hot as the patient can comfortably hold against closed eyelids (typically 40–45°C)
• Hold against the affected eye for 5–10 minutes
• Gently massage the eyelid towards the lash line after the compress
• Repeat 2–4 times daily

Common mistakes to correct:

• The flannel cools within 2 minutes — patients need to re-soak it repeatedly during the 10-minute session, or use a microwaveable eye mask (available OTC) that retains heat longer
• Squeezing or attempting to pop a stye or chalazion can spread infection to the surrounding tissue

Step 2: Lid hygiene (the prevention)

For patients with recurrent styes, daily lid hygiene is the intervention most likely to break the cycle. Options include:

Daily lid hygiene should be presented as a long-term maintenance routine, not a short course. Patients who stop lid cleaning when symptoms resolve will typically relapse.

Step 3: Recognise when to refer

Routine GP referral:

• A chalazion that has not resolved after 6–8 weeks of consistent warm compresses and lid hygiene
• Recurrent styes (three or more in 12 months) despite lid hygiene — may need oral antibiotics (doxycycline for meibomian gland dysfunction)
• Suspected rosacea contributing to recurrent styes — needs systemic management

Urgent referral (same day):

• Preseptal cellulitis — diffuse eyelid swelling, redness, warmth, and pain extending beyond the stye, sometimes with fever. This is a medical emergency if it progresses to orbital cellulitis
• Visual disturbance associated with the eyelid lump
• A chalazion in a patient over 60 that recurs in the same location after drainage — rarely, this can indicate sebaceous gland carcinoma, and biopsy is needed

When surgery is needed

Incision and curettage (I&C) is the definitive treatment for a persistent chalazion. It is a minor procedure performed under local anaesthetic, typically by an ophthalmologist or trained GP. The lid is everted, a small incision is made on the conjunctival side, and the granulomatous material is curetted out. Recovery is rapid, and recurrence at the same site is uncommon if the underlying blepharitis is managed.

Steroid injection (intralesional triamcinolone) is an alternative for patients who prefer to avoid surgery. Success rates are approximately 80% for a single injection, but recurrence is higher than with surgical drainage.

The pharmacy counter conversation

For the patient with their first stye, reassurance plus warm compress advice is sufficient. For the patient returning with their third stye this year, the conversation should shift to:

"Styes keep coming back when the oil glands in your eyelids are blocked. The best way to prevent them is a daily lid-cleaning routine — it takes about two minutes and keeps the glands clear. I can show you the products we have for lid hygiene."

This positions the pharmacy as the long-term management partner, not just the acute treatment stop.

PharmSee's pharmacy finder can help patients find pharmacies stocking specialist lid hygiene products, and pharmacists can explore roles in ophthalmology-focused services via the job listings.

Key points

• Recurrent styes indicate underlying meibomian gland dysfunction or blepharitis
• Warm compresses (5–10 minutes, 2–4 times daily) are first-line for both styes and chalazia
• Daily lid hygiene with purpose-made products prevents recurrence
• Refer persistent chalazia (>6–8 weeks) and recurrent styes (≥3 per year) to a GP
• Urgent referral for preseptal cellulitis or suspected sebaceous gland carcinoma in recurrent same-site chalazia in older adults

Sources: NICE CKS (Stye, Blepharitis), NHS (Stye). Article reflects guidance current as of April 2026.